NCT01292161View on ClinicalTrials.gov

Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Hepatitis C
Interventions
DRUG

Silymarin

Tab 210 mg, 630 mg, daily, six months.

Trial Locations (1)

Unknown

Al-zahra university hospital, Isfahan

All Listed Sponsors
lead

Isfahan University of Medical Sciences

OTHER

NCT01292161 - Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter